Tariq M. Haddad ,
- Echocardiography
- General Cardiology
- Nuclear Cardiology
- Research
Tariq M. Haddad, MD, FACC specializes in general cardiology, nuclear cardiology and has a special interest in conducting research and is the Director of the Research Center at Virginia Heart. He is board certified in cardiovascular disease and internal medicine. “I strive to educate each and every patient about their illness in a way the patient can understand," he said. "As nothing brings me more satisfaction than seeing the relief on a patient's face when they understand their illness and how we will solve it."
Dr. Haddad earned his medical degree from the Cornell University Medical College and pursued his internship and residency at University of Virginia Hospital. He completed multiple fellowships at Johns Hopkins University, National Heart, Lung and Blood Institute and the National Institutes of Health. He also pursued additional training in Cardiac MRI/CT Imaging.
Dr. Haddad currently serves as the Principal Investigator in many leading national clinical trials. Most recently, he served as a National Leader, one of only a few researchers across the country, in the ongoing ACCLAIM trial of a medication that treats high lipoprotein (a).
Dr. Haddad enjoys spending time with his family, playing tennis and basketball and cheering on his beloved alma mater Duke's basketball team!
Credentials
Medical School
- Cornell University Medical College
Residency
- University of Virginia Hospital | Cardiology
Fellowship
- Johns Hopkins University Hospital | Cardiovascular Disease
- National Heart, Lung & Blood Institute, NIH | Cardiac MRI/CT Imaging
Board Certifications
- Cardiovascular Disease
- Internal Medicine
Specialty Areas of Interest
- General Cardiology
- Nuclear Cardiology
- Echocardiography
Professional Associations
- American College of Cardiology | Fellow
Teaching Position
- Assistant Professor of Medicine | Virginia Commonwealth University, Medical College of Virginia
Leadership Positions
- Director, Clinical Research | Virginia Heart
Recognitions
- Top Doctor | Washingtonian Magazine
- Super Doctor | Washington Post Magazine
- Vance Award for Teaching Excellence | Inova Fairfax Hospital
Other Languages Spoken
- Arabic
Hospital Affiliations
- Inova Fairfax Hospital
Research Areas of Interest
- Cholesterol and lipid management, heart failure, antiplatelet therapy
Publications
- Lincoff AM, Ray KK, Sasiela WJ, Haddad T, Nicholls SJ, Li N, Cho L, Mason D, Libby P, Goodman SG, Nissen SE. Comparitive Cardiovascular Benefits of Bempedoic Acid and Statin Drugs. Journal of the American College of Cardiology (JACC). 2024 July 9; 84(2): 152-162.
- Minciunescu A, Rosner C, Kepplinger D, Del Castillo T, Overbeck D, Levy WS, O’Connor CM, Haddad TM. Novel Initiative Increasing GDMT Use Among Patients With Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 2024 June 5: S2213-1779 (24).
- Ridker PM, Lei L, Louie MJ, Haddad T, Nicholls SJ, Lincoff AM, Libby P, Nissen SE; Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13,970 Contemporary High-Risk Patients with Statin Intolerance. Circulation. 2024 Jan 2; 149(1):28-35.
- Lincoff M, Haddad T, P Ridker et al. Inflammation and Cholesterol as Predictors of Cardiovascular Events Among Statin Intolerant Patients: An Analysis of the CLEAR-Outcomes Trial. Abstract presentation at American Heart Association Scientific Sessions, November 2023.
- Minciunescu A, Gattani R, Kiernan J, Haddad T, and E Howard. Right Ventricular Perforation and Subsequent Tamponade Due to Fractured Inferior Vena Cava Filter Strut. Abstract presentation at the American Heart Association (AHA) Scientific Sessions, November 2023.
- Chatur S, Vaduganathan M, Haddad T, Scott Solomon, et al. Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. European Heart Journal. 2023 Aug 14; 44(31): 2930-2943.
- Ballantyne C, Baum S, Haddad T, M Shapiro et al. Lipoprotein (a) levels in a population with established atherosclerotic cardiovascular disease in the United States: a sub-analysis from the Lp(a) HERITAGE study. Poster presentation at the American Society for Preventive Cardiology (ASPC) 2023 Congress on CVD Prevention, July 2023.
- Lincoff M, Kausik KR, Sasiela W, Haddad T, Libby P, Nicholls S, S Nissen, et al. Estimating Cardiovascular Benefits of Bempedoic Acid beyond the CLEAR Outcomes trial- a post-hoc analysis using CTT and Per Protocol Analysis. Abstract presentation at 2023 Endocrine Society annual meeting June 2023.
- Ballantyne C, Baum S, Haddad T, M Shapiro et al. Lipoprotein (a) levels in a population with established atherosclerotic cardiovascular disease in the United States: a sub-analysis from the Lp(a) HERITAGE study. Poster presentation at the American College of Cardiology (ACC) Scientific Sessions, March 2023.
- Chatur S, Vaduganathan M, Claggett B, Vardeny O, Haddad T, Solomon S et al. Dapagliflozin Reduces Loop Diuretic Requirement Over Time in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction in the DELIVER trial. Abstract presentation at the American College of Cardiology (ACC) 2023 Scientific Sessions, March 2023.
- Mordini F, Haddad T, AE Arai et al. Diagnostic Accuracy of Stress Perfusion CMR in Comparison With Quantitative Coronary Angiography: Fully Quantitative, Semiquantitative, and Qualitative Assessment. JACC: Cardiovascular Imaging. January 2014; Volume 7, Issue 1: 14-22.
- Venkatesan C, Haddad T, S Gurpreet; Taking it from the Top-A Case of Apical Hypertrophic Cardiomyopathy [abstract]. Journal of Hospital Medicine. 8 Suppl 1:971.
"I am passionate about conducting and participating in research. As Director of the Virginia Heart Research Center we are committed to offering our patients the latest treatment advances and access to clinical trials."